These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

246 related articles for article (PubMed ID: 23642062)

  • 21. Epiblast-derived stem cells in embryonic and adult tissues.
    De Miguel MP; Arnalich Montiel F; Lopez Iglesias P; Blazquez Martinez A; Nistal M
    Int J Dev Biol; 2009; 53(8-10):1529-40. PubMed ID: 19757397
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Induced pluripotent stem cells: a new technology to study human diseases.
    Vitale AM; Wolvetang E; Mackay-Sim A
    Int J Biochem Cell Biol; 2011 Jun; 43(6):843-6. PubMed ID: 21458591
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Application of stem cell technology and nuclear transfer in animal models].
    Prelle K; Zakhartchenko V; Wolf E
    Z Arztl Fortbild Qualitatssich; 2002 Jul; 96(6-7):434-40. PubMed ID: 12219498
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Defining Human Pluripotency.
    Yilmaz A; Benvenisty N
    Cell Stem Cell; 2019 Jul; 25(1):9-22. PubMed ID: 31271751
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Therapeutic potential of motor neurons differentiated from embryonic stem cells and induced pluripotent stem cells.
    López-González R; Velasco I
    Arch Med Res; 2012 Jan; 43(1):1-10. PubMed ID: 22293229
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Directed differentiation of definitive hemogenic endothelium and hematopoietic progenitors from human pluripotent stem cells.
    Ditadi A; Sturgeon CM
    Methods; 2016 May; 101():65-72. PubMed ID: 26439174
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Orderly hematopoietic development of induced pluripotent stem cells via Flk-1(+) hemoangiogenic progenitors.
    Niwa A; Umeda K; Chang H; Saito M; Okita K; Takahashi K; Nakagawa M; Yamanaka S; Nakahata T; Heike T
    J Cell Physiol; 2009 Nov; 221(2):367-77. PubMed ID: 19562687
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Generation of induced pluripotent stem cells by efficient reprogramming of adult bone marrow cells.
    Kunisato A; Wakatsuki M; Kodama Y; Shinba H; Ishida I; Nagao K
    Stem Cells Dev; 2010 Feb; 19(2):229-38. PubMed ID: 19558219
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Hematopoietic defects and iPSC disease modeling: lessons learned.
    Kelley JM; Daley GQ
    Immunol Lett; 2013; 155(1-2):18-20. PubMed ID: 24076116
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Breakthrough in research on pluripotent stem cells and their application in medicine].
    Valdimarsdóttir G; Richter A
    Laeknabladid; 2015 Dec; 101(12):581-6. PubMed ID: 26656400
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Rho-associated kinase inhibitors promote the cardiac differentiation of embryonic and induced pluripotent stem cells.
    Cheng YT; Yeih DF; Liang SM; Chien CY; Yu YL; Ko BS; Jan YJ; Kuo CC; Sung LY; Shyue SK; Chen MF; Yet SF; Wu KK; Liou JY
    Int J Cardiol; 2015 Dec; 201():441-8. PubMed ID: 26313863
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Donor Dependent Variations in Hematopoietic Differentiation among Embryonic and Induced Pluripotent Stem Cell Lines.
    Féraud O; Valogne Y; Melkus MW; Zhang Y; Oudrhiri N; Haddad R; Daury A; Rocher C; Larbi A; Duquesnoy P; Divers D; Gobbo E; Brunet de la Grange P; Louache F; Bennaceur-Griscelli A; Mitjavila-Garcia MT
    PLoS One; 2016; 11(3):e0149291. PubMed ID: 26938212
    [TBL] [Abstract][Full Text] [Related]  

  • 33. iPS cell technology in regenerative medicine.
    Lengner CJ
    Ann N Y Acad Sci; 2010 Mar; 1192():38-44. PubMed ID: 20392216
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Hematopoietic development from human induced pluripotent stem cells.
    Lengerke C; Grauer M; Niebuhr NI; Riedt T; Kanz L; Park IH; Daley GQ
    Ann N Y Acad Sci; 2009 Sep; 1176():219-27. PubMed ID: 19796250
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The challenges and promises of blood engineered from human pluripotent stem cells.
    Dravid GG; Crooks GM
    Adv Drug Deliv Rev; 2011 Apr; 63(4-5):331-41. PubMed ID: 21232565
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Origins of mammalian hematopoiesis: in vivo paradigms and in vitro models.
    Lensch MW; Daley GQ
    Curr Top Dev Biol; 2004; 60():127-96. PubMed ID: 15094298
    [TBL] [Abstract][Full Text] [Related]  

  • 37. ES and iPS cell research for cardiovascular regeneration.
    Yamashita JK
    Exp Cell Res; 2010 Oct; 316(16):2555-9. PubMed ID: 20385126
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Induced pluripotent stem (iPS) cells offer a powerful new tool for the life sciences.
    Nakamura Y
    J Stem Cells Regen Med; 2010; 6(1):2-9. PubMed ID: 24693054
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Making gametes from pluripotent stem cells--a promising role for very small embryonic-like stem cells.
    Bhartiya D; Hinduja I; Patel H; Bhilawadikar R
    Reprod Biol Endocrinol; 2014 Nov; 12():114. PubMed ID: 25421462
    [TBL] [Abstract][Full Text] [Related]  

  • 40. In vivo evaluation of putative hematopoietic stem cells derived from human pluripotent stem cells.
    Hexum MK; Tian X; Kaufman DS
    Methods Mol Biol; 2011; 767():433-47. PubMed ID: 21822894
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.